Traussnigg S., Schattenberg J.M., Demir M., Wiegand J., Geier A., Teuber G., Hofmann W.P., Kremer A.E., Spreda F, Kluwe J., Petersen J., Boettler T., Rainer F., Halilbasic E., Greinwald R., Pröls M., Manns MP., Fickert P., Trauner M., on behalf of the Austrian/German NAFLD-norUDCA study group
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind,
randomised, placebo-controlled, phase 2 dose-finding trial
Lancet Gastroenterol Hepatol 2019
Published Online July 22, 2019; DOI: 10.1016/S2468-1253(19)30184-0
